[June 25, 2009]
FDA on Wednesday approved Watson Pharmaceuticals' generic version of the emergency contraceptive Plan B, the Wall Street Journal reports. The generic drug will be available without a prescription to women ages 18 and older on Aug. 24, when Duramed Pharmaceuticals' market exclusivity for Plan B expires (Kalish, Wall Street Journal, 6/25). The generic version will be available to women ages 17 and younger with a prescription, according to an FDA press release (FDA Web site, 6/24). Watson will market the generic version under the name Next Choice (AP/Washington Post, 6/24).
A one-time use pack of the brand-name product, Plan B, currently costs $49.99 through the online retailer DrugStore.com. According to Bloomberg, generic drugs usually cost 30% to 80% less than brand-name versions (Larkin, Bloomberg, 6/24).
The information contained in this publication reflects media coverage of women’s health issues and does not necessarily reflect the views of the National Partnership for Women & Families.
Search the Archives
Subscribe
Hot Topic
The greatest tribute we can pay Senator Kennedy is to redouble our efforts to see his vision for universal health care become reality.
So recommit yourself to one of the most important legislative challenges of our time.
Start by sharing your story!
Do you think we need health insurance reform, or is the status quo okay?
The Editors
Debra Ness, publisher & president, National Partnership
Marilyn Keefe, managing editor & director of reproductive health programs, National Partnership
Laura Hessburg, associate editor & senior health policy advisor, National Partnership
Christine Monahan, assistant editor & health program assistant, National Partnership
Justyn Ware, editor
Kimberley Lufkin, senior editor
Amanda Wolfe, editor-in-chief
Paula Fortner, Brittany Hackett, Ryan Holeywell, Julia Moss, Santosh Rao, Zach Swiss, Matt Wayt, staff writers
Michael Pogachar, copy editor
Tucker Ball, director of online marketing, National Partnership
